Hyperthyroidism.
Chaker L, Cooper DS, Walsh JP, Peeters RP.
Lancet. 2024 Feb 24;403(10428):768-780. doi: 10.1016/S0140-6736(23)02016-0. Epub 2024 Jan 23.
AMIODARONE AND THYROID DYSFUNCTION.
Medić F, Bakula M, Alfirević M, Bakula M, Mucić K, Marić N.
Acta Clin Croat. 2022 Aug;61(2):327-341. doi: 10.20471/acc.2022.61.02.20.
Amiodarone-induced thyrotoxicosis.
Anfinsen OG, Lima K.
Tidsskr Nor Laegeforen. 2021 Nov 8;141(16). doi: 10.4045/tidsskr.21.0047. Print 2021 Nov 9.
Antithyroid drugs.
Cooper DS.
N Engl J Med. 2005 Mar 3;352(9):905-17. doi: 10.1056/NEJMra042972.
Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature.
Maqdasy S, Benichou T, Dallel S, Roche B, Desbiez F, Montanier N, Batisse-Lignier M, Tauveron I.
Ann Endocrinol (Paris). 2019 Feb;80(1):54-60. doi: 10.1016/j.ando.2018.05.001. Epub 2018 Sep 17.
Amiodarone-induced thyreopaties.
Krausová A.
Cas Lek Cesk. 2025;164(3):94-99.
Drug-induced thyrotoxicosis: the surgical option.
Lorberboym M, Schachter P.
Isr Med Assoc J. 2007 Feb;9(2):79-82.
[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development].
Ermolaeva AS, Fadeev VV.
Probl Endokrinol (Mosk). 2023 Oct 23;70(3):9-22. doi: 10.14341/probl13348.
Exploring Current Diagnosis and Management of Amiodarone-induced Thyrotoxicosis.
Oktaviono YH, Mustofa A, Saputra PBT, Widiarti W, Faizah NN, Alkaff FF.
Am J Cardiol. 2025 May 1;242:75-81. doi: 10.1016/j.amjcard.2025.02.002. Epub 2025 Feb 7.
Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
Lo JC, Rivkees SA, Chandra M, Gonzalez JR, Korelitz JJ, Kuzniewicz MW.
Thyroid. 2015 Jun;25(6):698-705. doi: 10.1089/thy.2014.0434. Epub 2015 Apr 14.
